$52.66
0.250.48%
At Close: -
$52.66
00.00%
After Hours: Jul 19, 4:00 PM EDT
15 minutes delayed
Crinetics Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Crinetics Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CRNX | Crinetics Pharmaceuticals | -$0.94 | -$0.86 | — | — | $988.00K | $460.00K | — | — | 08/08/2024 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.85 | -$0.81 | -$0.93 | -14.81% | $2.68M | $260.00K | $640.00K | 146.15% | 05/09/2024 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.84 | -$0.86 | -$0.90 | -4.65% | $709.00K | $260.00K | $0.00 | -100.00% | 02/28/2024 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.78 | -$0.91 | -$1.01 | -10.99% | $458.00K | $120.00K | $346.00K | 188.33% | 11/07/2023 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.81 | -$0.86 | -$0.94 | -9.30% | $439.00K | $560.00K | $988.00K | 76.43% | 08/08/2023 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.73 | -$0.82 | -$0.85 | -3.66% | $3.13M | $300.00K | $2.68M | 793.00% | 05/04/2023 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.68 | -$0.82 | -$0.84 | -2.44% | $1.08M | $250.00K | $709.00K | 183.60% | 02/28/2023 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.73 | -$0.83 | -$0.78 | 6.02% | $0.00 | $170.00K | $458.00K | 169.41% | 11/14/2022 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.70 | -$0.67 | -$0.81 | -20.90% | $0.00 | $600.00K | $439.00K | -26.83% | 08/12/2022 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.69 | -$0.58 | -$0.73 | -25.86% | $0.00 | — | $3.13M | — | 05/12/2022 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.66 | -$0.62 | -$0.68 | -9.68% | $0.00 | — | $1.08M | — | 03/30/2022 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.56 | -$0.70 | -$0.73 | -4.29% | $0.00 | — | $0.00 | — | 11/05/2021 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.53 | -$0.61 | -$0.70 | -14.75% | $0.00 | — | $0.00 | — | 08/10/2021 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.71 | -$0.66 | -$0.69 | -4.55% | $71.00K | — | $0.00 | — | 05/06/2021 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.60 | -$0.58 | -$0.66 | -13.79% | $321.00K | — | $0.00 | — | 03/30/2021 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.60 | -$0.53 | -$0.56 | -5.66% | $505.00K | — | $0.00 | — | 11/06/2020 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.51 | — | -$0.53 | — | $0.00 | — | $0.00 | — | 08/07/2020 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.37 | — | -$0.71 | — | $367.00K | — | $71.00K | — | 05/08/2020 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.35 | — | -$0.60 | — | $781.00K | — | $321.00K | — | 03/09/2020 | Get Alert |
CRNX | Crinetics Pharmaceuticals | -$0.38 | — | -$0.60 | — | $548.00K | — | $505.00K | — | 11/12/2019 | Get Alert |
CRNX | Crinetics Pharmaceuticals | — | -$0.46 | -$0.51 | -10.87% | — | $150.00K | $0.00 | -100.00% | 08/13/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-0.93 | $-0.81 | -14.8 % |
Dec 2023 | 2024-02-28 | $-0.90 | $-0.86 | -4.65 % |
Sep 2023 | 2023-11-07 | $-1.01 | $-0.91 | -11.0 % |
Jun 2023 | 2023-08-08 | $-0.94 | $-0.86 | -9.30 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $640.00K | $260.00K | 146.2 % |
Dec 2023 | 2024-02-28 | $0 | $260.00K | -100.0 % |
Sep 2023 | 2023-11-07 | $346.00K | $120.00K | 188.3 % |
Jun 2023 | 2023-08-08 | $988.00K | $560.00K | 76.4 % |
Crinetics Pharmaceuticals (CRNX) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-0.93, which missed the estimate of $-0.81.
The Actual Revenue was $640K, which beat the estimate of $260K.
Browse earnings estimates, EPS, and revenue on all stocks.